Mesenchymal SC
Mesenchymal SC
Mesenchymal SC
mal
stem cel
l
Mesenchy
malst
em cel
l
Tr
ansmi
ssi
on
elect
ronmi
crogr
aph
ofamesenchy
mal
stem cel
l
di
spl
ayi
ngt
ypi
cal
ult
rast
ruct
ural
char
act
eri
sti
cs.
Det
ail
s
I
dent
if
ier
s
Lat
in Cel
l
ulamesenchy
mat
icapr
aecur
sor
ia
TH H2.
00.
01.
0.00008
Anat
omi
calt
ermsofmi
croanat
omy
[
edi
tonWi
ki
dat
a]
Mesenchy
mal st
em cell
s are mult
ipot
ent
str
omal cel
ls
thatcan dif
fer ent i
ate
int
oavari
etyofcell
ty
pes,i
ncl
udi
ng osteobl
asts (bonecel
ls)
,
chondrocyt
es (car
ti
lagecel ls) ,
my ocyt
es
(musclecel
ls)
and
adi
pocyt
es (
fatcell
swhi chgiveri
seto marr
owadi posetissue).
[1]
[2]
Cont
ent
s
1St
ruct
ure
o 1.
1Def
ini
ti
on
o 1.
2Mor
phol
ogy
2Locat
ion
o 2.
1Bonemar
row
o 2.
2Cor
dcel
l
s
o 2.
3Adi
poset
issue
o 2.
4Mol
arcel
l
s
o 2.
5Amni
oti
cfl
uid
3Funct
ion
o 3.
1Di
ff
erent
iat
ioncapaci
ty
o 3.
2Immunomodul
ator
yef
fect
s
o 3.
3Ant
imi
crobi
alpr
oper
ti
es
4Cl
i
nical
signi
fi
cance
o 4.
1Aut
oimmunedi
sease
o 4.
2Ot
herdi
seases
o 4.
3Det
ect
ion
5Resear
ch
6Hi
stor
y
7Seeal
so
8Ref
erences
9Ext
ernal
li
nks
St
ruct
ure[
edi
t]
Def
ini
ti
on[
edi
t]
Whil
etheter mesenchy
ms malstem cell
( mar
MSC)and r
owstromalcell
hav
ebeenused
i
nter
changeabl
yformanyyear
s,nei
thertermissuff
ici
entl
ydescr
ipt
ive:
Mesenchy
me
i
s embr
yoni
c connect
ivet
issue
thati
sder
ivedf
rom t
he
mesoder
m andt
hat
di
ff
erenti
atesint
o hematopoi
eti
c andconnect
ivet
issue,
wher
easMSCsdonotdi
ff
erent
iat
eint
o
hematopoi
eticcel
ls.[
3]
St
romal
cel
l
s ar
econnect
ivet
issuecel
l
sthatf
ormt
hesuppor
ti
vest
ruct
urei
nwhi
cht
he
f
unctionalcel
lsoftheti
ssuereside.Whil
ethisisanaccur
atedescr
ipt
ionf
oronef
unct
ionof
MSCs, theter
mf ai
l
st oconveytherelat
ivel
yrecent
lydi
scover
edrol
esofMSCsinther
epai
rof
t
issue.[
4]
Thet
erm encompassesmul
ti
pot
entcel
l
sder
ivedf
rom ot
hernon-
mar
row
ti
ssues,
such
as
placent
a,[
5]
umbi
li
calcord bl
ood,
adi
poset
issue,
adult
muscl
e,
cor
nealst
roma[6]
ort
hedent
al
pul
pof
deci
duous babyteeth.Thecell
sdonothavethecapaci
tytor
econst
itut
eanent i
reor
gan.
Mor
phol
ogy
[edi
t]
Humanbonemar
rowder
ivedMesenchy
mal
stem cel
lshowi
ngf
ibr
obl
ast
-l
ikemor
phol
ogyseenunderphase
cont
rastmi
croscope(
car
lzei
ssaxi
over
t40CFL)at63xmagni
fi
cat
ion
Locat
ion[
edi
t]
Bonemar
row[
edi
t]
Bonemar rowwast heori
ginalsourceofMSCs, andst
il
li
st hemostfr
equent
lyuti
li
zed.Thesebone
marrowstem cel l
sdonotcont ri
butetotheformati
onofbloodcell
sandsodonotexpr ess
the
hematopoi et
icstem cel
l
mar ker
CD34.Theyaresometimesref
err
edtoas bonemar r
owstromal
stem cel
l
s.[9]
Cor
dcel
l
s[edi
t]
Theyoungestandmostprimit
iveMSCscanbeobt
ainedfrom umbil
i
calcordt
issue,
namely
Wharton'
sjel
l
y andtheumbil
i
cal
cor
dbl
ood.Howev erMSCsarefoundinmuchhigher
concent
rat
ionintheWharton’
sjel
l
ycomparedt
ocordblood,whichi
sarichsourceof
hematopoi
eti
c
stem cel
ls.Theumbi
li
cal
cor
disavail
abl
eaf
terabir
th.I
tisnor
mal
l
ydiscardedandposesnori
skf
or
coll
ecti
on.TheseMSCsmayprov
et obeauseful
sourceofMSCsf
orcli
nicalappl
i
cat
ionsduet
o
thei
rprimiti
vepr
oper
ti
es.
Adi
poset
issue[
edi
t]
Adi
poset
issue
i
sar
ichsour
ceofMSCs(
oradi
pose-
der
ivedmesenchy
mal
stem cel
l
s,AdMSCs)
.[
10]
Mol
arcel
l
s[edi
t]
Thedev el
opi
ngtoot hbudofthemandibularthi
rdmolari
sar i
chsourceofMSCs.Whi letheyare
descr
ibedasmul ti
potent
,iti
spossi
blethattheyareplur
ipot
ent.Theyev
entual
lyform enamel,
dent
in,
bl
oodv essel
s,dentalpul
pandnervoustissues.Thesest
em cell
sarecapableofproducing
hepat
ocy t
es.
Amni
oti
cfl
uid[
edi
t]
Stem cel
lsarepresentin amnioti
cflui
d.Asmanyas1in100cellscol
l
ect
ed
duri
ng amniocentesi
s areplur
ipotentmesenchy
malst
em cel
l
s.[
11]
Funct
ion[
edi
t]
Di
ff
erent
iat
ioncapaci
ty[
edi
t]
MSCshav eagr eatcapaci t
yf orsel f-renewal whi lemai nt
ainingt heirmul t
ipotency .Beyondt hat,t
here
i
sl it
tlethatcanbedef ini
ti
v el
ysai d.Thest andar dt esttoconf ir
m mul tipotencyi sdifferenti
ationof
thecel l
sintoost eoblasts,adipocy tesandchondr ocytesaswel lasmy ocy tesandneur ons.MSCs
hav ebeenseent oev endi f
ferent iat ei nt oneur on- l
ikecells,
[
12]
butther ei sli
nger i
ngdoubtwhet herthe
MSC- deri
vedneur onsar efunct ional .[
13]
Thedegr eetowhi cht hecul turewi lldif
ferentiatevaries
amongi ndividualsandhowdi ffer ent i
at ionisi nduced, e.g.,chemi cal vs.mechani cal;
[
14]
anditisnot
clearwhet hert hisvar i
ati
oni sduet oadi f
ferentamountof" t
r ue"progeni torcellsinthecul tureor
variabledifferentiat
ioncapaci tiesofi ndi v
idual s'progenitors.Thecapaci t
yofcel ls
to proli
fer
at e and di
fferentiat
e isknownt odecr easewi ththeageoft hedonor ,aswel lasthet i
mei n
culture.Likewi se,whet herthisi sduet oadecr easei nthenumberofMSCsorachanget othe
existingMSCsi snotknown. ci
[ t
ati
onneeded]
I
mmunomodul
ator
yef
fect
s[edi
t]
MSCshaveaneffectoni nnateandspeci f
ici
mmunecel l
s.MSCspr oducemanymol eculeshavi
ng
i
mmunomodulatoryeffects.Theseincludeprostagl
andinE2( PGE2)
,[
15]
ni
tr
icoxi
de,
[
16]
indol
amin2,3-
di
oxi
genase(
IDO),IL-
6,andot hersurfacemar kers-FasL,
[
17]
PD-
L1/2.
MSCshav eanef fectonmacr ophages, neutrophi l
s,NKcel l
s,mastcel l
sanddendr iti
ccel l
sininnate
i
mmuni t
y.MSCsar eabletomi gratetothesi teofi njury ,wher etheypol arizet hroughPGE2
macr ophagesi nM2phenot ypewhi chischar act eri
zedbyanant i-
inflammat or yef f
ect.[
18]
Further
,
PGE2i nhi
bit
st heabi l
ityofmastcel l
stodegr anul ateandpr oduceTNF- α.
[
19]
[20]
Proli
ferationand
cytotoxicactivityofNKcel lsisinhibi
tedbyPGE2andI DO.MSCsal sor educet heex pressionofNK
cellreceptors-NKG2D, NKp44andNKp30. [
MSCsi
21]
nhi bitrespi
rator yf
lareandapopt osisof
neutrophilsbypr oductionofcy tokinesIL-6andI L-8.
[
22]
Di f
ferent
iationandexpr essionofdendr it
iccel
l
surfacemar ker si sinhibit
edbyI L-6andPGE2ofMSCs. [
23]
Theimmunosuppr essiveeffect sofMSC
alsodependonI L-10,butitisnotcer t
ainwhet hertheypr oduceital one,oronl ysti
mul ateot hercell
s
topr oduceit.
[24]
Ant
imi
crobi
alpr
oper
ti
es[
edi
t]
MSCscanpr oduceanti
mi crobi
alpepti
des( AMPs)
.Theseincl
udehumancat hel
ici
dinLL-37,
[
31]
β-
defensines,
[
32]
li
pocal
in2
[
33]
andhepcidi
n.
[
34]
MSCseffecti
vel
ydecreasenumberofcol oniesofboth
gram negativeandgr am positi
vebacter
iabypr oducti
onoftheseAMPs.I naddi
ti
on,thesame
anti
mi crobi
al ef
fectoft
heenzy meIDOpr oducedbyMSCswasf ound.[
35]
Cl
i
nical
signi
fi
cance[
edi
t]
Ty
pical
grossappear
anceofat
ubul
arcar
ti
lagi
nousconst
ructengi
neer
edf
rom amni
oti
cmesenchy
mal
stem
cel
l
s
Mesenchymalst
em cel
lsinthebodycanbeactivat
edand mobil
ized
ifneeded.However,t
he
ef
fi
ciencyisl
ow.Fori
nstance,damagetomusclesheal
sv er
yslowlybutfurt
herstudyint
o
mechanismsofMSCact i
onmaypr ovi
deavenuesfori
ncreasi
ngt hei
rcapacit
yforti
ssuerepai
r.
[
36]
[37]
Aut
oimmunedi
sease[
edi
t]
Clini
cal studi esi nv esti
gatingtheef f
icacyofmesenchy malstem cell
sint reati
ngdi seasesarein
preli
mi narydev elopment ,
part
icularl
yf orunderstanding aut
oimmunedi seases, graftversushost
disease, Cr ohn' sdi sease,
multipl
escl erosi
s,
systemicl upuserythematosus and systemic
sclerosis.[
38]
[
39]
Asof2014, nohigh-qualit
ycli
nicalresearchprovidesev i
denceofef ficacy,and
numer ousi nconsi stenciesandpr oblemsexi stinther esear
chmet hods.[
39]
Ot
herdi
seases[
edi
t]
Manyoftheear l
yclini
calsuccessesusingi ntrav
enoust r
ansplant
ati
oncamei nsyst
emi cdi
seases
suchas
graf
tv ersushostdisease and
sepsi s.Di
r ecti
njecti
onorplacementofcellsintoasi tein
needofr
epairmaybet hepreferr
edmet hodoft reatment,asvasculardel
i
v erysuf
fersfrom a
"pul
monaryf
irstpassef f
ect"wherei nt
ravenousi nject
edcel l
saresequesteredinthelungs.
[40]
Det
ect
ion[
edi
t]
TheInternati
onal SocietyforCel l
ularTher apy( I
SCT)haspr oposedasetofst andardstodef
ine
MSCs.Acel l
canbecl assifi
edasanMSCi fitshowspl asti
cadherentpr
oper ti
esundernormal
cul
tureconditionsandhasaf i
broblast-li
kemor phol
ogy.Infact,
somearguet hatMSCsand
fi
brobl
ast sarefunct i
onall
yi denti
cal.[
41]
Furt
her more,MSCscanunder goost eogenic,adi
pogeni
cand
chondrogenicdifferenti
ation exv i
vo.Thecul tur
edMSCsal soexpressonthei r
surf
ace CD73, CD90 and CD105, whi l
el ackingtheexpression
of
CD11b,
CD14,
CD19,
CD34, CD45, CD79a and HLA-
DR surfacemarker
s.[
42]
Resear
ch[
edi
t]
Themaj ori
tyofmoder ncul turetechni
quesstill
takeacolony-for
mingunit-f
ibrobl
asts(CFU-F)
approach,whererawunpur i
fi
edbonemar roworf icol
l
-puri
fi
edbonemar r
ow Mononuclearcel
l
are
pl
ateddi r
ectl
yint
o cellculture
platesorf
lasks.Mesenchy malstem cel
ls,butnotredbloodcell
sor
haemat opoet
icprogenitors,areadherenttoti
ssuecul t
ureplasti
cwithi
n24t o48hour s.Howev er
,at
l
eastonepubl i
cati
onhasi dentif
iedapopulationofnon-adherentMSCst hatarenotobt ai
nedbythe
di
rect-
plati
ngtechnique.[
43]
Other
f
lowcytometr
y-basedmet hodsall
owt hesort
ingofbonemar r
owcell
sforspecif
icsurf
ace
markers,
suchas
STRO- 1.[
44]
STRO-1+cel
lsaregenerall
ymorehomogenousandhav ehigherrat
esof
adher
enceandhigherratesofpr oli
fer
ati
on,buttheexactdi
ff
erencesbet
weenSTRO- 1+cell
sand
MSCsar
enotcl
ear
.[
45]
Methodsofi
mmunodepl
eti
onusi
ngsucht
echni
quesas
MACS
hav
eal
sobeenusedi
nthenegat
ive
sel
ecti
onofMSCs.
[
46]
Thesupplementati
onofbasalmediawi t
h fetalbov i
neser
um orhuman
plat
eletl
ysat
e i
scommoni n
MSCculture.Pr
iortot
heuseofpl at
eletly
sat esforMSCcul t
ure,
thepat
hogeninacti
vat
ionpr
ocessis
recommendedtopr ev
entpathogentransmi ssi
on.[
47]
Hi
stor
y[edi
t]
I
n1924,Russian-bornmor phol
ogist
AlexanderA.Maximov
(Russi an:
АлександрАлександрович
Максимов);usedext ensiv
ehistol
ogicalfi
ndingst
oident
if
yasi ngularty
peofprecur
sorcell
withi
n
mesenchy
met hatdev el
opsint
odi f
ferentt
ypesofbloodcel
ls.
[48]
Scienti
sts
ErnestA.McCul l
och
and JamesE.Til
l f
ir
str eveal
edthecl onalnat
ureofmar r
owcel l
sin
the1960s.[
49]
[
50]
An exvi
vo
assayforexamini
ngthecl onogenicpotent ialofmult
ipot
entmar r
owcells
wasl at
errepor tedint
he1970sbyFr i
edenst
einandcol leagues.
[
51]
[
52]
Inthisassaysyst
em, str
omal
cell
swer eref erredtoascolony
-for
mingunit-
fi
broblasts(CFU-f)
.
Thefir
stclini
calt
ri
alsofMSCswer ecomplet
edi n1995whenagr oupof15pati
ent
swer ei
nject
ed
wit
hcul t
uredMSCst otestt
hesafetyoft
hetreatment.Si
ncethen,ov
er200cl
ini
calt
ri
alshavebeen
st
arted.Howev er
,mostaresti
l
linthesaf
etystageoftest
ing.
[
5]
Subsequentexper i
mentati
onrev eal edt hepl
astici
tyofmar r
owcell
sandhowt hei
rfateisdetermined
byenvir
onment alcues.Cult
uri
ngmar rowst r
omal cellsint
hepresenceofosteogenicsti
muli such
ascor
as bicacid,i
nor
gani
cphosphat e and dexamet hasone
coul
dpr omotet
heirdif
ferenti
ati
on
i
nto
osteoblasts.Incont
rast,
theaddi tionoft
ransforminggrowt
hfactor
-bet
a (TGF-b)could
i
nduce chondrogenic
markers.
[ci
tat
ionneeded]